Related Experiment Videos
The changing profile of hypercalcemia in a tertiary care setting in North India: an 18-month retrospective study
Mohammad Shafi Kuchay1, Parjeet Kaur1, Sunil Kumar Mishra1
1Division of Endocrinology and Diabetes, Medanta-The Medicity, Sector 38, Gurgaon, Haryana, India.
Insights
This study analyzed hypercalcemia profiles in Indian hospital patients. Malignancy and primary hyperparathyroidism were common causes, with emerging trends in liver disease and vitamin D toxicity.
Area of Science:
- Endocrinology
- Internal Medicine
- Clinical Biochemistry
Background:
- Hypercalcemia is a common electrolyte imbalance encountered in clinical practice.
- Understanding the etiological profile of hypercalcemia is crucial for effective patient management.
Purpose of the Study:
- To determine the etiological profile of hypercalcemia in patients presenting to a tertiary care hospital in North India.
- To identify trends and less common causes of hypercalcemia.
Main Methods:
- Retrospective analysis of patient data from January 2014 to June 2015.
- Inclusion of patients with measured calcium levels and diagnosed hypercalcemia.
- Categorization of hypercalcemia into transient and sustained forms.
Main Results:
- The incidence of hypercalcemia was 2.09% (2.04% sustained, 0.05% transient).
- Sustained hypercalcemia causes included malignancy (23.1%) and primary hyperparathyroidism (PHPT, 21.9%).
- Unusual causes identified were hypercalcemia of advanced chronic liver disease (n=34) and vitamin D toxicosis (n=21).
Conclusions:
- Malignancy and PHPT remain leading causes of sustained hypercalcemia.
- Emerging trends of hypercalcemia associated with chronic liver disease and vitamin D toxicity require clinical attention.
- Awareness of evolving hypercalcemia patterns is essential for accurate diagnosis and treatment.
Abstract:
This retrospective study was undertaken to determine the profile of hypercalcemia in all patients who presented to Medanta-The Medicity, a tertiary care hospital in North India. A total of 255,830 patients presented to the hospital during 1st January 2014 till 30th June 2015 (18 months). Among them calcium measurement was done in 26,297 (10.2%) patients. A total of 552 patients was found to have hypercalcemia. Among them, 15 (2.7%) patients had transient hypercalcemia and 537 (97.3%) had sustained hypercalcemia. The incidence of hypercalcemia was 2.09%, being transient in 0.05% and sustained in 2.04%. The most common causes in the sustained group were malignancy (23.1%) followed by primary hyperparathyroidism (PHPT, 21.9%). Most cases of PHPT were asymptomatic. Interestingly, we found emergence of two unusual groups of hypercalcemia, namely hypercalcemia of advanced chronic liver disease (n = 34) and vitamin D toxicosis (n = 21) in the non-parathyroid group of hypercalcemia. This changing pattern of hypercalcemia should be kept in mind while evaluating a patient of hypercalcemia in a hospital setting.
Related Concept Videos
Tertiary Healthcare System
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Skeleton and Calcium Homeostasis
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Chronic Kidney Disease IV: Nursing Management